Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies-Reference-Cited by-同舟云学术

Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies

Published:2012-07-25 Issue:1 Volume:1263 Page:43-56
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

Gupta Ira V.,Jewell Roxanne C.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.2012.06661.x/fullpdf

Reference62 articles.

1. NCCN “NCCN Clinical Practice Guidelines in Oncology. NCCN Non-Hodgkin's lymphoma Guidelines Vers 2,” NCCN http://www.nccn.org/professionals/physician_gls/f_guidelines.asp

2. SEER “Stat Fact Sheets: Chronic Lymphocytic Leukemia,” Surveillance Epidemiology and End Results http://seer.cancer.gov/statfacts/html/clyl.html

3. SEER “Fast Stats: Chronic Lymphocytic Leukemia Prevalence,” Surveillance Epidemiology and End Results http://seer.cancer.gov/faststats/selections.php?run=runit&output=2&data=5&statistic=9&race=1&sex=1&age=1&series=cancer&cancer=93#Output

4. SEER “Stat Fact Sheets: Non-Hodgkin Lymphoma,” Surveillance Epidemiology and End Results http://seer.cancer.gov/statfacts/html/nhl.html#

5. ACS “Detailed Guide: ‘What Is Non-Hodgkin Lymphoma?’,” American Cancer Society http://www.cancer.org/Cancer/Non-HodgkinLymphoma/DetailedGuide/non-hodgkin-lymphoma-types-of-non-hodgkin-lymphoma

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CD20 antibody treatment for B-cell malignancies;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

2. CD20-Negative Primary Bone Marrow Large B Cell Lymphoma: A Report of Two Cases with Review of Literature;South Asian Journal of Cancer;2023-08-24

3. Application of Antibody Fragments in ADCs;Antibody-Drug Conjugates and Cellular Metabolic Dynamics;2023

4. Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas;American Journal of Clinical Dermatology;2022-07-19

5. S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2022-04